Effector triggered immunity activation of innate immunity in metazoans by bacterial effectors

Virulence

Volumn 5, Issue 7, 2014, Pages 697-702

  Rajamuthiah, Rajmohan ^a,b   Mylonakis, Eleftherios ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Actin cytoskeleton; Animal cells; DAMP; Innate immunity; MAMP; Metazoans; PAMP; Pore forming toxin; PRR; Translation inhibition

Indexed keywords

BACTERIAL TOXIN; EFFECTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PATTERN RECOGNITION RECEPTOR; PORE FORMING CYTOTOXIC PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL PROTEIN; BACTERIAL SECRETION SYSTEM;

CAENORHABDITIS ELEGANS; CYTOSKELETON; EFFECTOR TRIGGERED IMMUNITY; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INNATE IMMUNITY; INVERTEBRATE; LEGIONELLA PNEUMOPHILA; MAMMAL CELL; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; REVIEW; RNA TRANSLATION; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; TYPE III SECRETION SYSTEM; UNFOLDED PROTEIN RESPONSE; ANIMAL; BACTERIAL INFECTION; BACTERIAL SECRETION SYSTEM; BACTERIUM; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PROTEIN SYNTHESIS;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; BACTERIAL TOXINS; IMMUNITY, INNATE; INVERTEBRATES; PROTEIN BIOSYNTHESIS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; VIRULENCE FACTORS;

EID: 84908229298     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.29091     Document Type: Review

References (80)

1. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004; 5:971-4; PMID:15454919; http://dx.doi.org/10.1038/ni1004-971
2. Sansonetti PJ. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 2006; 7:1237-42; PMID:17110939; http://dx.doi.org/10.1038/ni1420
3. Mattoo S, Lee YM, Dixon JE. Interactions of bacterial effector proteins with host proteins. Curr Opin Immunol 2007; 19:392-401; PMID:17662586; http://dx.doi.org/10.1016/j.coi.2007.06.005
4. Ribet D, Cossart P. Pathogen-mediated posttranslational modifications: A re-emerging field. Cell 2010; 143:694-702; PMID:21111231; http://dx.doi.org/10.1016/j.cell.2010.11.019
5. Fontana MF, Banga S, Barry KC, Shen X, Tan Y, Luo ZQ, Vance RE. Secreted bacterial effectors that inhibit host protein synthesis are critical for induction of the innate immune response to virulent Legionella pneumophila. PLoS Pathog 2011; 7:e1001289; PMID:21390206; http://dx.doi.org/10.1371/journal.ppat.1001289
6. Fontana MF, Vance RE. Two signal models in innate immunity. Immunol Rev 2011; 243:26-39; PMID:21884165; http://dx.doi.org/10.1111/j.1600-065X.2011.01037.x
7. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801; PMID:16497588; http://dx.doi.org/10.1016/j. cell.2006.02.015
8. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20; PMID:20303872; http://dx.doi.org/10.1016/j. cell.2010.01.022
9. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130:1071-82; PMID:17889651; http://dx.doi.org/10.1016/j.cell.2007.09.008
10. Barbalat R, Lau L, Locksley RM, Barton GM. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 2009; 10:1200-7; PMID:19801985; http://dx.doi.org/10.1038/ni.1792
11. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296:301-5; PMID:11951032; http://dx.doi.org/10.1126/science.1071059
12. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290:C917-24; PMID:16267105; http://dx.doi.org/10.1152/ajpcell.00401.2005
13. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007; 13:1042-9; PMID:17767165; http://dx.doi.org/10.1038/nm1638
14. He RL, Zhou J, Hanson CZ, Chen J, Cheng N, Ye RD. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 2009; 113:429-37; PMID:18952897; http://dx.doi.org/10.1182/blood-2008-03-139923
15. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13:397-411; PMID:23702978; http://dx.doi.org/10.1038/nri3452
16. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009; 30:766-75; PMID:19538928; http://dx.doi.org/10.1016/j.immuni.2009.06.004
17. Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, Ryffel B, Swanson JA, Müller M, Blander JM. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 2011; 474:385-9; PMID:21602824; http://dx.doi.org/10.1038/nature10072
18. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010; 10:131-44; PMID:20098461; http://dx.doi.org/10.1038/nri2707
19. Roy CR, Mocarski ES. Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol 2007; 8:1179-87; PMID:17952043; http://dx.doi.org/10.1038/ni1528
20. Spoel SH, Dong X. How do plants achieve immunity? Defence without specialized immune cells. Nat Rev Immunol 2012; 12:89-100; PMID:22273771; http://dx.doi.org/10.1038/nri3141
21. Tseng TT, Tyler BM, Setubal JC. Protein secretion systems in bacterial-host associations, and their description in the Gene Ontology. BMC Microbiol 2009; 9(Suppl 1):S2; PMID:19278550; http://dx.doi.org/10.1186/1471-2180-9-S1-S2
22. Desvaux M, Hébraud M, Talon R, Henderson IR. Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue. Trends Microbiol 2009; 17:139-45; PMID:19299134; http://dx.doi.org/10.1016/j.tim.2009.01.004
23. Jones JD, Dangl JL. The plant immune system. Nature 2006; 444:323-9; PMID:17108957; http://dx.doi.org/10.1038/nature05286
24. Stuart LM, Paquette N, Boyer L. Effector-triggered versus pattern-triggered immunity: how animals sense pathogens. Nat Rev Immunol 2013; 13:199-206; PMID:23411798; http://dx.doi.org/10.1038/nri3398
25. Huffman DL, Abrami L, Sasik R, Corbeil J, van der Goot FG, Aroian RV. Mitogen-activated protein kinase pathways defend against bacterial poreforming toxins. Proc Natl Acad Sci U S A 2004; 101:10995-1000; PMID:15256590; http://dx.doi.org/10.1073/pnas.0404073101
26. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006; 126:1135-45; PMID:16990137; http://dx.doi.org/10.1016/j. cell.2006.07.033
27. Bebien M, Hensler ME, Davanture S, Hsu LC, Karin M, Park JM, Alexopoulou L, Liu GY, Nizet V, Lawrence T. The pore-forming toxin β hemolysin/cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity. PLoS Pathog 2012; 8:e1002812; PMID:22829768; http://dx.doi.org/10.1371/journal. ppat.1002812
28. Meinzer U, Barreau F, Esmiol-Welterlin S, Jung C, Villard C, Léger T, Ben-Mkaddem S, Berrebi D, Dussaillant M, Alnabhani Z, et al. Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe 2012; 11:337-51; PMID:22520462; http://dx.doi.org/10.1016/j.chom.2012.02.009
29. Bruno VM, Hannemann S, Lara-Tejero M, Flavell RA, Kleinstein SH, Galán JE. Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog 2009; 5:e1000538; PMID:19662166; http://dx.doi.org/10.1371/journal.ppat.1000538
30. McEwan DL, Kirienko NV, Ausubel FM. Host translational inhibition by Pseudomonas aeruginosa Exotoxin A Triggers an immune response in Caenorhabditis elegans. Cell Host Microbe 2012; 11:364-74; PMID:22520464; http://dx.doi.org/10.1016/j.chom.2012.02.007
31. Dunbar TL, Yan Z, Balla KM, Smelkinson MG, Troemel ER. C. elegans detects pathogen-induced translational inhibition to activate immune signaling. Cell Host Microbe 2012; 11:375-86; PMID:22520465; http://dx.doi.org/10.1016/j. chom.2012.02.008
32. Fontana MF, Shin S, Vance RE. Activation of host mitogen-activated protein kinases by secreted Legionella pneumophila effectors that inhibit host protein translation. Infect Immun 2012; 80:3570-5; PMID:22851749; http://dx.doi.org/10.1128/IAI.00557-12
33. Raymond B, Crepin VF, Collins JW, Frankel G. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-κB-dependent manner. Cell Microbiol 2011; 13:1881-93; PMID:21848814; http://dx.doi.org/10.1111/j.1462-5822.2011.01666.x
34. Boyer L, Magoc L, Dejardin S, Cappillino M, Paquette N, Hinault C, Charriere GM, Ip WK, Fracchia S, Hennessy E, et al. Pathogen-derived effectors trigger protective immunity via activation of the Rac2 enzyme and the IMD or Rip kinase signaling pathway. Immunity 2011; 35:536-49; PMID:22018470; http://dx.doi.org/10.1016/j.immuni.2011.08.015
35. Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 2013; 13:679-92; PMID:23954936; http://dx.doi.org/10.1038/nri3495
36. Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene 2006; 25:6758-80; PMID:17072327; http://dx.doi.org/10.1038/sj.onc.1209943
37. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27:693-733; PMID:19302050; http://dx.doi.org/10.1146/annurev.immunol.021908.132641
38. Buchon N, Broderick NA, Chakrabarti S, Lemaitre B. Invasive and indigenous microbiota impact intestinal stem cell activity through multiple pathways in Drosophila. Genes Dev 2009; 23:2333-44; PMID:19797770; http://dx.doi.org/10.1101/gad.1827009
39. Chatterjee M, Ip YT. Pathogenic stimulation of intestinal stem cell response in Drosophila. J Cell Physiol 2009; 220:664-71; PMID:19452446; http://dx.doi.org/10.1002/jcp.21808
40. Chakrabarti S, Liehl P, Buchon N, Lemaitre B. Infection-induced host translational blockage inhibits immune responses and epithelial renewal in the Drosophila gut. Cell Host Microbe 2012; 12:60-70; PMID:22817988; http://dx.doi.org/10.1016/j. chom.2012.06.001
41. Zhu W, Banga S, Tan Y, Zheng C, Stephenson R, Gately J, Luo ZQ. Comprehensive identification of protein substrates of the Dot/Icm type IV transporter of Legionella pneumophila. PLoS One 2011; 6:e17638; PMID:21408005; http://dx.doi.org/10.1371/journal.pone.0017638
42. Isberg RR, O’Connor TJ, Heidtman M. The Legionella pneumophila replication vacuole: making a cosy niche inside host cells. Nat Rev Microbiol 2009; 7:13-24; PMID:19011659; http://dx.doi.org/10.1038/nrmicro1967
43. Shin S, Case CL, Archer KA, Nogueira CV, Kobayashi KS, Flavell RA, Roy CR, Zamboni DS. Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophila. PLoS Pathog 2008; 4:e1000220; PMID:19043549; http://dx.doi.org/10.1371/journal.ppat.1000220
44. Desalermos A, Muhammed M, Glavis-Bloom J, Mylonakis E. Using C. elegans for antimicrobial drug discovery. Expert Opin Drug Discov 2011; 6:645-52; PMID:21686092; http://dx.doi.org/10.1517/174604 41.2011.573781
45. Rajamuthiah R, Fuchs BB, Jayamani E, Kim Y, Larkins-Ford J, Conery A, Ausubel FM, Mylonakis E. Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus. PLoS One 2014; 9:e89189; PMID:24586584; http://dx.doi.org/10.1371/journal.pone.0089189
46. Melo JA, Ruvkun G. Inactivation of conserved C. elegans genes engages pathogen-and xenobiotic-associated defenses. Cell 2012; 149:452-66; PMID:22500807; http://dx.doi.org/10.1016/j. cell.2012.02.050
47. Hubber A, Roy CR. Modulation of host cell function by Legionella pneumophila type IV effectors. Annu Rev Cell Dev Biol 2010; 26:261-83; PMID:20929312; http://dx.doi.org/10.1146/annurev-cellbio-100109-104034
48. Tattoli I, Sorbara MT, Vuckovic D, Ling A, Soares F, Carneiro LA, Yang C, Emili A, Philpott DJ, Girardin SE. Amino acid starvation induced by invasive bacterial pathogens triggers an innate host defense program. Cell Host Microbe 2012; 11:563-75; PMID:22704617; http://dx.doi.org/10.1016/j. chom.2012.04.012
49. Ghislat G, Patron M, Rizzuto R, Knecht E. Withdrawal of essential amino acids increases autophagy by a pathway involving Ca2+/calmodulindependent kinase kinase-β (CaMKK-β). J Biol Chem 2012; 287:38625-36; PMID:23027865; http://dx.doi.org/10.1074/jbc.M112.365767
50. Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010; 22:124-31; PMID:20034776; http://dx.doi.org/10.1016/j.ceb.2009.11.014
51. Bokoch GM. Regulation of innate immunity by Rho GTPases. Trends Cell Biol 2005; 15:163-71; PMID:15752980; http://dx.doi.org/10.1016/j. tcb.2005.01.002
52. Thrasher AJ, Burns SO. WASP: a key immunological multitasker. Nat Rev Immunol 2010; 10:182-92; PMID:20182458; http://dx.doi.org/10.1038/nri2724
53. Misra A, George B, Rajmohan R, Jain N, Wong MH, Kambadur R, Thanabalu T. Insulin receptor substrate protein 53kDa (IRSp53) is a negative regulator of myogenic differentiation. Int J Biochem Cell Biol 2012; 44:928-41; PMID:22465711; http://dx.doi.org/10.1016/j.biocel.2012.02.020
54. Misra A, Rajmohan R, Lim RP, Bhattacharyya S, Thanabalu T. The mammalian verprolin, WIRE induces filopodia independent of N-WASP through IRSp53. Exp Cell Res 2010; 316:2810-24; PMID:20678498; http://dx.doi.org/10.1016/j. yexcr.2010.07.015
55. Lorenzi R, Brickell PM, Katz DR, Kinnon C, Thrasher AJ. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 2000; 95:2943-6; PMID:10779443
56. Leverrier Y, Lorenzi R, Blundell MP, Brickell P, Kinnon C, Ridley AJ, Thrasher AJ. Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J Immunol 2001; 166:4831-4; PMID:11290758; http://dx.doi.org/10.4049/jimmunol.166.8.4831
57. Rajmohan R, Raodah A, Wong MH, Thanabalu T. Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae. FEMS Yeast Res 2009; 9:1226-35; PMID:19817875; http://dx.doi.org/10.1111/j.1567-1364.2009.00581.x
58. Rajmohan R, Meng L, Yu S, Thanabalu T. WASP suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of WIP. Biochem Biophys Res Commun 2006; 342:529-36; PMID:16488394; http://dx.doi.org/10.1016/j. bbrc.2006.01.160
59. Lemichez E, Aktories K. Hijacking of Rho GTPases during bacterial infection. Exp Cell Res 2013; 319:2329-36; PMID:23648569; http://dx.doi.org/10.1016/j.yexcr.2013.04.021
60. Brodsky IE, Medzhitov R. Targeting of immune signalling networks by bacterial pathogens. Nat Cell Biol 2009; 11:521-6; PMID:19404331; http://dx.doi.org/10.1038/ncb0509-521
61. Cornelis GR, Wolf-Watz H. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 1997; 23:861-7; PMID:9076724; http://dx.doi.org/10.1046/j.1365-2958.1997.2731623.x
62. Black DS, Bliska JB. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol Microbiol 2000; 37:515-27; PMID:10931345; http://dx.doi.org/10.1046/j.1365-2958.2000.02021.x
63. Németh ZH, Deitch EA, Davidson MT, Szabó C, Vizi ES, Haskó G. Disruption of the actin cytoskeleton results in nuclear factor-kappaB activation and inflammatory mediator production in cultured human intestinal epithelial cells. J Cell Physiol 2004; 200:71-81; PMID:15137059; http://dx.doi.org/10.1002/jcp.10477
64. Gerhard R, Tatge H, Genth H, Thum T, Borlak J, Fritz G, Just I. Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB. J Biol Chem 2005; 280:1499-505; PMID:15531589; http://dx.doi.org/10.1074/jbc. M406014200
65. Hardt WD, Chen LM, Schuebel KE, Bustelo XR, Galán JES. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 1998; 93:815-26; PMID:9630225; http://dx.doi.org/10.1016/S0092-8674(00)81442-7
66. Lerm M, Selzer J, Hoffmeyer A, Rapp UR, Aktories K, Schmidt G. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun 1999; 67:496-503; PMID:9916051
67. Lemonnier M, Landraud L, Lemichez E. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 2007; 31:515-34; PMID:17680807; http://dx.doi.org/10.1111/j.1574-6976.2007.00078.x
68. Hobbie S, Chen LM, Davis RJ, Galán JE. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol 1997; 159:5550-9; PMID:9548496
69. Parker MW, Feil SC. Pore-forming protein toxins: from structure to function. Prog Biophys Mol Biol 2005; 88:91-142; PMID:15561302; http://dx.doi.org/10.1016/j.pbiomolbio.2004.01.009
70. Aroian R, van der Goot FG. Pore-forming toxins and cellular non-immune defenses (CNIDs). Curr Opin Microbiol 2007; 10:57-61; PMID:17234446; http://dx.doi.org/10.1016/j.mib.2006.12.008
71. Freche B, Reig N, van der Goot FG. The role of the inflammasome in cellular responses to toxins and bacterial effectors. Semin Immunopathol 2007; 29:249-60; PMID:17805541; http://dx.doi.org/10.1007/s00281-007-0085-0
72. Ratner AJ, Hippe KR, Aguilar JL, Bender MH, Nelson AL, Weiser JN. Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J Biol Chem 2006; 281:12994-8; PMID:16520379; http://dx.doi.org/10.1074/jbc.M511431200
73. Kloft N, Busch T, Neukirch C, Weis S, Boukhallouk F, Bobkiewicz W, Cibis I, Bhakdi S, Husmann M. Pore-forming toxins activate MAPK p38 by causing loss of cellular potassium. Biochem Biophys Res Commun 2009; 385:503-6; PMID:19497299; http://dx.doi.org/10.1016/j.bbrc.2009.05.121
74. McNeil PL, Steinhardt RA. Plasma membrane disruption: repair, prevention, adaptation. Annu Rev Cell Dev Biol 2003; 19:697-731; PMID:14570587; http://dx.doi.org/10.1146/annurev.cellbio.19.111301.140101
75. Kotzka J, Müller-Wieland D, Roth G, Kremer L, Munck M, Schürmann S, Knebel B, Krone W. Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J Lipid Res 2000; 41:99-108; PMID:10627507
76. Idone V, Tam C, Goss JW, Toomre D, Pypaert M, Andrews NW. Repair of injured plasma membrane by rapid Ca2+-dependent endocytosis. J Cell Biol 2008; 180:905-14; PMID:18316410; http://dx.doi.org/10.1083/jcb.200708010
77. Park JM, Ng VH, Maeda S, Rest RF, Karin M. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J Exp Med 2004; 200:1647-55; PMID:15611291; http://dx.doi.org/10.1084/jem.20041215
78. Gelber SE, Aguilar JL, Lewis KL, Ratner AJ. Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J Bacteriol 2008; 190:3896-903; PMID:18390664; http://dx.doi.org/10.1128/JB.01965-07
79. Kim YJ, Shin HS, Lee JH, Jung YW, Kim HB, Ha UH. Pneumolysin-mediated expression of β-defensin 2 is coordinated by p38 MAP kinase-MKP1 in human airway cells. J Microbiol 2013; 51:194-9; PMID:23625220; http://dx.doi.org/10.1007/s12275-013-2579-x
80. Stassen M, Müller C, Richter C, Neudörfl C, Hültner L, Bhakdi S, Walev I, Schmitt E. The streptococcal exotoxin streptolysin O activates mast cells to produce tumor necrosis factor alpha by p38 mitogen-activated protein kinase-and protein kinase C-dependent pathways. Infect Immun 2003; 71:6171-7; PMID:14573633; http://dx.doi.org/10.1128/IAI.71.11.6171-6177.2003